Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination
暂无分享,去创建一个
S. Hauser | J. Lee | H. von Büdingen | C. Genain | Cameron B. Nabavi | Antje Fuhrmann | H.-Christian von Büdingen
[1] P. Villoslada,et al. Immune Responses Against the Myelin/Oligodendrocyte Glycoprotein in Experimental Autoimmune Demyelination , 2001, Journal of Clinical Immunology.
[2] R. Maxwell,et al. Marmoset Fine B Cell and T Cell Epitope Specificities Mapped onto a Homology Model of the Extracellular Domain of Human Myelin Oligodendrocyte Glycoprotein , 2002, Neurobiology of Disease.
[3] H. Lassmann,et al. Inflammation in the nervous system: The human perspective , 2001, Glia.
[4] Pablo Villoslada,et al. Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates , 2001, European journal of immunology.
[5] R. Hohlfeld,et al. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls , 2001, Journal of Neuroimmunology.
[6] Carlos F. Barbas,et al. Phage display: a Laboratory manual , 2014 .
[7] A. Cross,et al. B cells and antibodies in CNS demyelinating disease , 2001, Journal of Neuroimmunology.
[8] H. Wekerle,et al. Myelin oligodendrocyte glycoprotein‐DNA vaccination induces antibody‐mediated autoaggression in experimental autoimmune encephalomyelitis , 2000, European journal of immunology.
[9] N. Chiorazzi,et al. Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients1 , 2000, The Journal of Immunology.
[10] S. Baranzini,et al. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. , 1999, Journal of immunology.
[11] W. Poewe,et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. , 1999, Brain : a journal of neurology.
[12] U. Brehm,et al. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG) , 1999, Journal of Neuroimmunology.
[13] R. Sobel,et al. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice , 1999, Journal of Neuroimmunology.
[14] A. Ben-nun,et al. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. , 1999, Archives of neurology.
[15] S. Hauser,et al. Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.
[16] Y. Qin,et al. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. , 1998, The Journal of clinical investigation.
[17] D. Gilden,et al. Restricted use of VH4 Germline segments in an acute multiple sclerosis brain , 1998, Annals of neurology.
[18] R. Hohlfeld,et al. Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.
[19] S. Hauser,et al. Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.
[20] S. Hauser,et al. Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion , 1996, Methods.
[21] T. Johns,et al. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. , 1996, International immunology.
[22] C. Brosnan,et al. Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.
[23] N. Letvin,et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.
[24] H. Lassmann,et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat , 1995, Journal of Neuroimmunology.
[25] O. Majdic,et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.
[26] H. Lassmann,et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.
[27] C. Linington,et al. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily , 1992, Journal of neuroscience research.
[28] T. Olsson,et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.
[29] H. Link,et al. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls , 1991, Journal of Neuroimmunology.
[30] R. Jemmerson,et al. Affinity consideration in the design of synthetic vaccines intended to elicit antibodies. , 1989, Molecular immunology.
[31] H. Lassmann,et al. Differential Ultrastructural Localization of Myelin Basic Protein, Myelin/Oligodendroglial Glycoprotein, and 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in the CNS of Adult Rats , 1989, Journal of neurochemistry.
[32] H. Weiner,et al. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.
[33] C B Anfinsen,et al. An immunologic approach to the conformational equilibria of polypeptides. , 1972, Proceedings of the National Academy of Sciences of the United States of America.